SCHEMBL13554346

SCHEMBL13554346

CCc1cnc2ccc(OC)nc2c1

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CSF1R P07333 1/20 0.41
PDE10A Q9Y233 8/20 0.40
MTNR1A P48039 1/20 0.40
MTNR1B P49286 1/20 0.40
PDGFRB P09619 3/20 0.38
PDGFRA P16234 3/20 0.38
PIK3CA P42336 2/20 0.38
PIK3CD O00329 1/20 0.38
PIP5K1C O60331 1/20 0.38
PIK3CB P42338 1/20 0.38
PI4KA P42356 1/20 0.38
PIK3CG P48736 1/20 0.38
PI4KB Q9UBF8 1/20 0.38
HPGD P15428 1/20 0.37
NPC1 O15118 1/20 0.37
HTT P42858 1/20 0.37
RAB9A P51151 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
RXFP1 Q9HBX9 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16705355 0.78 CYP1A2 (0.40) PDE10AMTNR1AMTNR1BPIK3CAPIK3CD
SCHEMBL15942810 0.77 CYP1A2 (0.44) CSF1RPDE10APDGFRBPDGFRAPIK3CA
SCHEMBL622678 0.77 PDGFRB (0.48) CSF1RPDE10APDGFRBPDGFRAHPGD
SCHEMBL13552130 0.77 HTT (0.41) CSF1RPDE10AMTNR1AMTNR1BPDGFRB
SCHEMBL25113003 0.76 EGFR (0.41) CSF1RPDE10APDGFRBPDGFRAPIK3CA
SCHEMBL622358 0.76 HPGD (0.41) CSF1RPDE10AMTNR1AMTNR1BPDGFRB
SCHEMBL21746277 0.76 ALDH1A1 (0.43) HPGDNPC1RAB9A
SCHEMBL622192 0.76 PIK3CA (0.42) CSF1RPDE10APDGFRBPDGFRAPIK3CA
SCHEMBL19808389 0.76 CYP1A2 (0.46) PDE10AMTNR1AMTNR1BHPGDNPC1
SCHEMBL17244314 0.76 PDGFRB (0.40) CSF1RPDE10APDGFRBPDGFRAPIK3CA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120270893-A1 SUBSTITUTED ACETYL-COA CARBOXYLASE INHIBITORS PFIZER INC. (US) 2012-10-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120270893-A1 SUBSTITUTED ACETYL-COA CARBOXYLASE INHIBITORS ACACA, ACACB, ACAT1 CSF1R 2743/4885PDE10A 3233/4885MTNR1A 2244/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.